Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 0 | 11.991.019 | 3.649.482 | 4 | ||
2010 | 0 | 29.979.967 | 1.969.534 | 3 |
Total number of partners: 3258
Partner loyalty:
Frequent Partner: (> 2 projects): 1721
Rare Partner: 1537
Frequent / Rare Partner Ratio: 1.12
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-11-01 | Pathogen and commensal immunity compared in a reversible infection model that uncouples immunity from pathogen immune evasion | ReversibleInfection | participant | 1.499.992 | 1 |
2011-09-01 | Mechanisms of hygiene-mediated immune dysregulation and impact on the susceptibility to allergic and autoimmune diseases | HygieneandImmunity | participant | 1.500.000 | 1 |
2011-02-01 | PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies | PanCareSurFup | participant | 5.993.695 | 17 |
2011-01-01 | New approaches for the targeted therapy of Non-Small Cell Lung Cancer | LUNGTARGET | participant | 2.997.332 | 10 |
2010-11-01 | The European Network for Translational Research in Atrial Fibrillation | EUTRAF | participant | 11.997.333 | 20 |
2010-11-01 | ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours | ASSET | participant | 11.999.156 | 19 |
2010-01-01 | Fatty liver: Inhibition of Progression | FLIP | participant | 5.983.478 | 17 |